Osimertinib vs Sacubitril-Valsartan
Osimertinib vs Sacubitril-Valsartan: Overview
This comparison examines the pharmacological differences between Osimertinib and Sacubitril-Valsartan.
Mechanism of Action
Osimertinib: Third-generation irreversible EGFR TKI targeting T790M resistance mutation and activating mutations.
Sacubitril-Valsartan: Angiotensin receptor-neprilysin inhibitor (ARNI) combining neprilysin inhibition with AT1 receptor blockade.
Pharmacokinetics
Half-life: Osimertinib β 48 hours; Sacubitril-Valsartan β 11.5 hours.
Chemical Properties
Molecular Formula: Osimertinib β C28H33N7O2; Sacubitril-Valsartan β C24H29N2O5.
Molecular Weight: Osimertinib β 499.6050 g/mol; Sacubitril-Valsartan β 414.5010 g/mol.
Type: Osimertinib β Small molecule; Sacubitril-Valsartan β Small molecule.